Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Runesson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Neuropeptides|May 27, 2009
A novel GalR2-specific peptide agonistJohan Runesson, Indrek Saar, Linda Lundström, et al.
Frontiers in Endocrinology|December 13, 2012
Galanin receptors and ligandsKristin E B Webling, Johan Runesson, Tamas Bartfai, et al.
Neurochemical Research|November 30, 2012
Novel galanin receptor subtype specific ligand in depression like behaviorIndrek Saar, Johan Runesson, Jaak Järv, et al.
Neuropeptides|April 23, 2017
GalR3 mediates galanin proliferative effects on postnatal hippocampal precursorsD Khan, M Khan, Johan Runesson, et al.
Neuropeptides|September 5, 2016
Ala<sup>5</sup>-galanin (2-11) is a GAL<sub>2</sub>R specific galanin analogueKristin Webling, Johan Runesson, Andreas Lang, et al.
Toxicology and Applied Pharmacology|March 10, 2010
Neurofunctional endpoints assessed in human neuroblastoma SH-SY5Y cells for estimation of acute systemic toxicityHelena Gustafsson, Johan Runesson, Jessica Lundqvist, et al.
Behavioural Brain Research|November 13, 2012
Galanin, through GalR1 but not GalR2 receptors, decreases motivation at times of high appetitive behaviorMaria E Anderson, Johan Runesson, Indrek Saar, et al.
Neurochemistry International|February 22, 2011
Novel galanin receptor subtype specific ligands in feeding regulationIndrek Saar, Johan Runesson, Ilan McNamara, et al.
Neurochemistry International|September 7, 2010
Determining receptor-ligand interaction of human galanin receptor type 3Johan Runesson, Ulla E Sollenberg, Wiktor Jurkowski, et al.
Journal of Diabetes Research|April 30, 2016
Central Administration of Galanin Receptor 1 Agonist Boosted Insulin Sensitivity in Adipose Cells of Diabetic RatsZhenwen Zhang, Penghua Fang, Biao He, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Neuropeptides|May 27, 2009
A novel GalR2-specific peptide agonistJohan Runesson, Indrek Saar, Linda Lundström, et al.
Frontiers in Endocrinology|December 13, 2012
Galanin receptors and ligandsKristin E B Webling, Johan Runesson, Tamas Bartfai, et al.
Neurochemical Research|November 30, 2012
Novel galanin receptor subtype specific ligand in depression like behaviorIndrek Saar, Johan Runesson, Jaak Järv, et al.
Neuropeptides|April 23, 2017
GalR3 mediates galanin proliferative effects on postnatal hippocampal precursorsD Khan, M Khan, Johan Runesson, et al.
Neuropeptides|September 5, 2016
Ala<sup>5</sup>-galanin (2-11) is a GAL<sub>2</sub>R specific galanin analogueKristin Webling, Johan Runesson, Andreas Lang, et al.
Toxicology and Applied Pharmacology|March 10, 2010
Neurofunctional endpoints assessed in human neuroblastoma SH-SY5Y cells for estimation of acute systemic toxicityHelena Gustafsson, Johan Runesson, Jessica Lundqvist, et al.
Behavioural Brain Research|November 13, 2012
Galanin, through GalR1 but not GalR2 receptors, decreases motivation at times of high appetitive behaviorMaria E Anderson, Johan Runesson, Indrek Saar, et al.
Neurochemistry International|February 22, 2011
Novel galanin receptor subtype specific ligands in feeding regulationIndrek Saar, Johan Runesson, Ilan McNamara, et al.
Neurochemistry International|September 7, 2010
Determining receptor-ligand interaction of human galanin receptor type 3Johan Runesson, Ulla E Sollenberg, Wiktor Jurkowski, et al.
Journal of Diabetes Research|April 30, 2016
Central Administration of Galanin Receptor 1 Agonist Boosted Insulin Sensitivity in Adipose Cells of Diabetic RatsZhenwen Zhang, Penghua Fang, Biao He, et al.
Pageof 2